Journals / JAREM / 2013 / Cilt: 3 - Sayı: 3

Obez Hastaların tedavisinde intragastrik balonun etkinliği: Retrospektif klinik çalışma

Effectiveness of intragastric balloon treatment for obese patients: Retrospective clinical trial

Journal
JAREM
Pages
97–99
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The intragastric balloon can play a role for the temporary weight reduction of morbidly obese patients in diet supporting, as well as in the preoperative treatment of patient candidates for bariatric surgery or other surgical procedures in order to decrease morbidity and mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Obesity is a serious and chronic disease with genetic and environmental interference.
📊
Key Findings & Data:Intragastric balloons were performed between 2012 January-2013 December.
💡
Conclusion & Impact:The intragastric balloon can play a role for the temporary weight reduction of morbidly obese patients in diet supporting, as well as in the preoperative treatment of patient candidates for bariatric surgery or other surgical procedures in order to decrease morbidity and mortality.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Obesity is a serious and chronic disease with genetic and environmental interference. Several treatment modalities exist such as medical treatment, surgical treatment, endoscopic interventions. Methods: Thirteen patients’ data were evaluated retrospectively at the Erzincan University Medical Faculty Hospital Endoscopy Unit. Intragastric balloons were performed between 2012 January-2013 December. When patients gain the desired weight, approximately 8 to 12 months later; the balloons were removed. Results: The mean duration of gastric balloons in patients was 10.0±1.22 months. It was determined that the mean weight loss within the prescribed time was 25.1±5.5 kg. There is a statistically significant difference among the values when comparing the values before and after gastric balloon (p=0.001) Conclusion: Intragastric balloon replacement is a safe and effective procedure for weight reduction. The intragastric balloon can play a role for the temporary weight reduction of morbidly obese patients in diet supporting, as well as in the preoperative treatment of patient candidates for bariatric surgery or other surgical procedures in order to decrease morbidity and mortality.

Özet

Amaç: Obezite çevresel ve genetik faktörlerle iştirakli ciddi ve kronik bir hastalıktır. Medikal, cerrahi ve endoskopik girişimler olarak birkaç tedavi şekli mevcuttur. Yöntemler: Erzincan Tıp Fakültesi Endoskopi Ünitesindeki 13 hastanın verileri retrospektif olarak değerlendirildi. Intragastrik balonlar 2012 Ocak-2013 Aralık tarihleri arasında uygulandı. Ortalama 8-12 ay sonra, hastalar istenilen kiloya gerileyince, balonlar çıkarıldı. Bulgular: Gastrik balonların ortalama kalma süresi 10,0±1,22 ay olarak bulundu. Belirtilen sürede ortalama kilo kaybı 25,1±5,5 kg. saptandı. Değerleri gastrik balon öncesi ve sonrası olarak kıyasladığımızda istatiksel olarak belirgin fark bulundu (p=0,001). Sonuç: Kilo vermek için intragastrik balon yerleştirilmesi güvenli ve efektif prosedürdür. Intragastrik balon uygulaması diyet desteğinde ki morbid obez hastalarda geçici kilo azaltımı; bariatrik tedaviye gönüllü hastaların preoperatif tedavileri için ve diğer cerrahi girişimlerde morbiditeyi-mortaliteyi azaltmak için idealdir.

🔖

Cite This Article

PEKER, K., ISIK, A., ÇİMEN, O., DEMİRTAŞ, L., KUYRUKLUYILDIZ, U. (2013). Obez Hastaların tedavisinde intragastrik balonun etkinliği: Retrospektif klinik çalışma. JAREM, Cilt: 3 - Sayı: 3, 97–99. https://ajindex.com/articles/270408

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Caglar E, Dobrucali A, Bal K. Gastric balloon to treat obesity: Filled with air or fluid? Dig Endosc 2013; 25: 502-7. [CrossRef] 2.Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – the evidence report. National Institutes of Health Obes Res 1998; 6: 51-209. 3.Schneider BE, Mun EC. Surgical management of morbid obesity. Diabetes Care.2005; 28: 475-80. [CrossRef] 4.Bult MJ, van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol 2008; 158: 135-45. [CrossRef] 5.McFarland RJ, Grundy A, Gazet JC, Pilkinton TRE. The intragastric ballon: a novel idea proved ineffective. Br J Surg 1987; 74: 137-9. [CrossRef] 6.Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982; 1: 198-9. [CrossRef] 7.Benjamin SB, Maher KA, Cattau EL, Collen MJ, Flcisher DE, Lewis JH, et al. Double blind controlled trial of the Garren–Edward gastric bubble: an adjunctive treatment for exogenous obesity.Gastroenter- ology 1988; 95: 581-8. 8.Mathus-Vliegen EMH, Tytgat GNJ. Intragastric balloons for morbid obesity: results, patient tolerance and balloon life span. Br J Surg 1990; 77: 77-9. [CrossRef] 9.Hogan RB, Johnston JH, Long BW, Sones JQ, Ardell Hinton L, Dunge J, et al. A double blind, randomised, sham controlled trial of the gastric bubble for obesity. Gastrointest Endosc 1989; 35: 381-5. [CrossRef] 10.Meshkinpour H, Hsu D, Farivar S. Effect of gastric bubble as a weight reduction device: a controlled, crossover study. Gastroenterology 1988; 95: 589-92. 11.Isik A, Alimoglu O, Okan I, Bas G, Turgut H, Sahin M. Dieulafoy Lesion in the Stomach Case Rep Gastroenterol. 2008; 2: 469-73. [CrossRef]